Apex Biotechnology Corp.

TWSE:1733 주식 보고서

시가총액: NT$2.9b

Apex Biotechnology 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Thomas Y. Shen

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권10.4%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간6.8yrs

최근 관리 업데이트

Recent updates

Apex Biotechnology (TWSE:1733) Will Be Hoping To Turn Its Returns On Capital Around

Aug 06
Apex Biotechnology (TWSE:1733) Will Be Hoping To Turn Its Returns On Capital Around

Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings

Mar 21
Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings

Apex Biotechnology's (TPE:1733) Returns On Capital Not Reflecting Well On The Business

Apr 17
Apex Biotechnology's (TPE:1733) Returns On Capital Not Reflecting Well On The Business

Is Apex Biotechnology (TPE:1733) Using Too Much Debt?

Mar 30
Is Apex Biotechnology (TPE:1733) Using Too Much Debt?

Is Apex Biotechnology Corp. (TPE:1733) A Good Fit For Your Dividend Portfolio?

Mar 10
Is Apex Biotechnology Corp. (TPE:1733) A Good Fit For Your Dividend Portfolio?

Is Apex Biotechnology Corp.'s (TPE:1733) Stock On A Downtrend As A Result Of Its Poor Financials?

Feb 17
Is Apex Biotechnology Corp.'s (TPE:1733) Stock On A Downtrend As A Result Of Its Poor Financials?

A Look At Apex Biotechnology's (TPE:1733) Share Price Returns

Jan 27
A Look At Apex Biotechnology's (TPE:1733) Share Price Returns

Returns On Capital At Apex Biotechnology (TPE:1733) Paint An Interesting Picture

Jan 06
Returns On Capital At Apex Biotechnology (TPE:1733) Paint An Interesting Picture

These 4 Measures Indicate That Apex Biotechnology (TPE:1733) Is Using Debt Safely

Dec 16
These 4 Measures Indicate That Apex Biotechnology (TPE:1733) Is Using Debt Safely

Is Apex Biotechnology Corp.'s (TPE:1733) 4.5% Dividend Worth Your Time?

Nov 22
Is Apex Biotechnology Corp.'s (TPE:1733) 4.5% Dividend Worth Your Time?

CEO

Thomas Y. Shen

no data

테뉴어

Dr. Thomas Y. S. Shen, Ph D serves as Chairman, Chief Executive Officer and General Manager of Apex Biotechnology Corp. Dr. Shen served as Supervisor/Corporate Representative at Sheng Da Venture Capital. D...

이사회 구성원

이름위치테뉴어보상소유권
Thomas Y. Shen
Chairmanno data데이터 없음10.38%
NT$ 301.4m
Meng Yang
Vice GMno data데이터 없음0.28%
NT$ 8.2m
Yung-Luh Tsaih
Independent Director3.3yrs데이터 없음데이터 없음
I-Tan Chih
Independent Directorno data데이터 없음데이터 없음
Pai Ming
Independent Director6.8yrs데이터 없음데이터 없음
Jin-Chang Bou
Independent Director6.8yrs데이터 없음데이터 없음

6.8yrs

평균 재임 기간

경험이 풍부한 이사회: 1733 의 이사회는 경험(평균 재직 기간 6.8 년)으로 간주됩니다.